You are here

  • Home
  • Archive
  • Volume 67, Issue 10
  • Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis

Article info

Article menu

Download PDFPDF

Recommendations
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis

Authors

  1. D Aletaha, Division of Rheumatology, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Vienna, Austria; daniel.aletaha{at}meduniwien.ac.at
View Full Text

Citation

Karonitsch T, Aletaha D, Boers M, et al
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis
Annals of the Rheumatic Diseases 2008;67:1365-1373.

Publication history

  • Accepted June 5, 2008
  • First published September 12, 2008.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism